228 related articles for article (PubMed ID: 19606218)
1. Levels of C-reactive protein associated with high and very high cardiovascular risk are prevalent in patients with rheumatoid arthritis.
Graf J; Scherzer R; Grunfeld C; Imboden J
PLoS One; 2009 Jul; 4(7):e6242. PubMed ID: 19606218
[TBL] [Abstract][Full Text] [Related]
2. Clinical disease activity and acute phase reactant levels are discordant among patients with active rheumatoid arthritis: acute phase reactant levels contribute separately to predicting outcome at one year.
Kay J; Morgacheva O; Messing SP; Kremer JM; Greenberg JD; Reed GW; Gravallese EM; Furst DE
Arthritis Res Ther; 2014 Feb; 16(1):R40. PubMed ID: 24485007
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the disease activity score using erythrocyte sedimentation rate and C-reactive protein in African Americans with rheumatoid arthritis.
Tamhane A; Redden DT; McGwin G; Brown EE; Westfall AO; Reynolds RJ; Hughes LB; Conn DL; Callahan LF; Jonas BL; Smith EA; Brasington RD; Moreland LW; Bridges SL
J Rheumatol; 2013 Nov; 40(11):1812-22. PubMed ID: 23950187
[TBL] [Abstract][Full Text] [Related]
4. Test-retest reliability of the disease activity score 28 CRP (DAS28-CRP), the simplified disease activity index (SDAI) and the clinical disease activity index (CDAI) in rheumatoid arthritis when based on patient self-assessment of tender and swollen joints.
Heegaard C; Dreyer L; Egsmose C; Madsen OR
Clin Rheumatol; 2013 Oct; 32(10):1493-500. PubMed ID: 23754243
[TBL] [Abstract][Full Text] [Related]
5. Differences in disease activity measures in patients with rheumatoid arthritis who achieved DAS, SDAI, or CDAI remission but not Boolean remission.
Aletaha D; Wang X; Zhong S; Florentinus S; Monastiriakos K; Smolen JS
Semin Arthritis Rheum; 2020 Apr; 50(2):276-284. PubMed ID: 31590930
[TBL] [Abstract][Full Text] [Related]
6. Thresholds for the 28-joint disease activity score (DAS28) using C-reactive protein are lower compared to DAS28 using erythrocyte sedimentation rate in early rheumatoid arthritis.
Kuriya B; Schieir O; Lin D; Xiong J; Pope J; Boire G; Haraoui B; Thorne JC; Tin D; Hitchon C; Jamal S; Keystone E; Bykerk VP;
Clin Exp Rheumatol; 2017; 35(5):799-803. PubMed ID: 28339365
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the disease activity score using the erythrocyte sedimentation rate and C-reactive protein levels in Koreans with rheumatoid arthritis.
Son KM; Kim SY; Lee SH; Yang CM; Seo YI; Kim HA
Int J Rheum Dis; 2016 Dec; 19(12):1278-1283. PubMed ID: 26200604
[TBL] [Abstract][Full Text] [Related]
8. Disease Activity Score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis patients in Japan.
Matsui T; Kuga Y; Kaneko A; Nishino J; Eto Y; Chiba N; Yasuda M; Saisho K; Shimada K; Tohma S
Ann Rheum Dis; 2007 Sep; 66(9):1221-6. PubMed ID: 17369281
[TBL] [Abstract][Full Text] [Related]
9. Soluble urokinase plasminogen activator receptor (suPAR) in the assessment of inflammatory activity of rheumatoid arthritis patients in remission.
Toldi G; Bekő G; Kádár G; Mácsai E; Kovács L; Vásárhelyi B; Balog A
Clin Chem Lab Med; 2013 Feb; 51(2):327-32. PubMed ID: 22718576
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptor γ agonist effect on rheumatoid arthritis: a randomized controlled trial.
Ormseth MJ; Oeser AM; Cunningham A; Bian A; Shintani A; Solus J; Tanner S; Stein CM
Arthritis Res Ther; 2013; 15(5):R110. PubMed ID: 24020899
[TBL] [Abstract][Full Text] [Related]
11. Infliximab equivalently suppresses oxidative stress compared to tocilizumab among well-controlled patients with rheumatoid arthritis.
Kizaki K; Yamashita F; Hayashi T; Funakoshi N
Int J Rheum Dis; 2018 Oct; 21(10):1815-1821. PubMed ID: 27778459
[TBL] [Abstract][Full Text] [Related]
12. Remission in rheumatoid arthritis by different criteria does not converge over the inflammatory markers.
Chandrashekara S; Priyanka BU
Int J Rheum Dis; 2013 Jun; 16(3):291-6. PubMed ID: 23981750
[TBL] [Abstract][Full Text] [Related]
13. Semi-quantitative analysis of
Ravikanth R; Singh JK
World J Nucl Med; 2020; 19(4):347-352. PubMed ID: 33623503
[No Abstract] [Full Text] [Related]
14. Which measure of inflammation to use? A comparison of erythrocyte sedimentation rate and C-reactive protein measurements from randomized clinical trials of golimumab in rheumatoid arthritis.
Crowson CS; Rahman MU; Matteson EL
J Rheumatol; 2009 Aug; 36(8):1606-10. PubMed ID: 19531760
[TBL] [Abstract][Full Text] [Related]
15. Visualization of DAS28, SDAI, and CDAI: the magic carpets of rheumatoid arthritis.
Futó G; Somogyi A; Szekanecz Z
Clin Rheumatol; 2014 May; 33(5):623-9. PubMed ID: 24599677
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of disease activity indices in Korean patients with rheumatoid arthritis.
Park SY; Lee H; Cho SK; Choi CB; Sung YK; Bae SC
Rheumatol Int; 2012 Feb; 32(2):545-9. PubMed ID: 21305296
[TBL] [Abstract][Full Text] [Related]
17. Performance of routine assessment of patient index data 3 (RAPID3) in monitoring disease activity of Chinese rheumatoid arthritis patients.
Zhang X; Xie A; Wang Y; Deng X; Geng Y; Ji L; Hao Y; Li G; Zhang Z
Int J Rheum Dis; 2018 Nov; 21(11):1940-1945. PubMed ID: 30402934
[TBL] [Abstract][Full Text] [Related]
18. Effect of Sanhuangyilong decoction plus methotrexate on tumor necrosis factor alpha and interferon gamma in serum and synovial fluid in rheumatoid arthritis patients with symptom pattern of damp heat obstruction.
Liu D; Yan J; Yun M; Yang M; Luo Y; Zhang J; Guo M; Yang M; Yuan W; Zou W; Li H; Hu Y
J Tradit Chin Med; 2016 Oct; 36(5):625-33. PubMed ID: 29933531
[TBL] [Abstract][Full Text] [Related]
19. Effect of human immunodeficiency virus infection on disease activity in rheumatoid arthritis: a retrospective study in South Africans.
Tarr G; Makda M; Musenge E; Tikly M
J Rheumatol; 2014 Aug; 41(8):1645-9. PubMed ID: 25028384
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the DAS28-CRP and DAS28-ESR in patients with rheumatoid arthritis.
Sengul I; Akcay-Yalbuzdag S; Ince B; Goksel-Karatepe A; Kaya T
Int J Rheum Dis; 2015 Jul; 18(6):640-5. PubMed ID: 26013310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
